However, decreased expression of CCR5, known to contribute to recruitment of inflammatory cells, was observed in colon tissue of mice treated with B. fragilis (Fig. 3), suggesting that reduced expression of the inflammatory and infiltration-inducing factor CCR5 is associated with the protective role of B. fragilis against the development of colitis-associated colon cancer. Here, CCR5 is linked to malignant colon neoplasm.